Expression of Bcl-2 family proteins during chemotherapeutic agents-induced apoptosis in the hepatoblastoma HepG2 cell line

British Journal of Biomedical Science

Volumn 56, Issue 2, 1999, Pages 114-122

  Luo, Dan ^a   Cheng, Samuel C S ^a   Xie, Yong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Apoptosis; Bcl 2 family proteins, expression; Hepatoblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; DNA FRAGMENT; DOX; DOXORUBICIN; PACLITAXEL; PHOSPHATIDYLSERINE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOPLASM; DNA DEGRADATION; DOWN REGULATION; ENZYME LOCALIZATION; GENE REPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0032792467     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Reed JC, Kitada S, Takayama S, Miyashita T. Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukaemia cell lines. Ann Oncol 1994; 5(Suppl. 1):S61-5.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
3. Wyllie AH, Kerr JFR, Currie AR. Cell death, the significance of apoptosis. Int Rev Cytol 1980; 6:251-306.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-62.
5. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood 1996; 88:386-401.
6. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7:541-6.
7. Tang C, Willingham MC, Reed JC et al. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 1994; 8:1960-9.
8. Ohmori T, Podack ER, Nishio K et al. Apoptosis of lung cancer cells caused by anti-cancer agents (MMC, CPT-11, ADM) is inhibited by BCL-2. Biochem Biophys Res Commun 1993; 192:30-6.
9. Dole M, Nunez G, Merchant AK et al. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994; 54:3253-9.
10. Shouval D, Adler R. Human hepatoma associated antigens: opportunities for immunotherapy. In: Thomas HC, Waters J, eds. Immunology of liver disease. Immunology and Medicine Series Vol. 21. Dordrecht: Kluwer Academic Publishers, 1994: 69-83.
11. Venook AP. Treatment of hepatocellular carcinoma: too many options. J Clin Oncol 1994; 12:1323-34.
12. Tu Y, Xu FH, Liu J et al. Up-regulated expression of Bcl-2 in multiple cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. Blood 1996; 88:1805-12.
13. L, or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Jnt J Cancer 1996; 67:608-14.
14. Rowinsky EK. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res 1989; 49:4640-7.
15. Tamuar T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T. Interferon-gamma induced ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemias cell-line. Biochem Biophys Res Commun 1996; 229:21-6.
16. Kaplinsky C, Lotem J, Sachs L. Protection of human myeloid leukemic cells against doxorubicin-induced apoptosis by granulocyte-macrophage colony-stimulating factor and interleukin 3. Leukemia 1996; 10:460-5.
17. Scudiero DA, Shoemaker RH, Paull KD et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48:4827-33.
18. Brus I, Glass GBJ. Estimation of cytotoxic injury to gastric parietal cells by trypan blue exclusion test, following by haematoxylin eosin counterstaining of fixed smears. Stain Technol 1973; 48:127-32.
19. Jiang MC, Yang-Yen HF, Lin JK, Yen JJY. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 1996; 13:609-16.
20. Brown DG, Sun XM, Cohen GM. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 1993; 268:3037-9.
21. Oberhammer F, Wilson JW, Dive C et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993; 12:3679-84.
22. Halder S, Jena N, Croce CM. Antiapoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem Cell Biol 1994; 72:455-62.
23. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7:541-6.
24. Haldar S, Chintapalli J, Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996; 56:1253-5.
25. Reed JC. Bcl-2 and B-cell neoplasia: dysregulation of programmed cell death in cancer. In: Rertino JR, ed. Encyclopedia of cancer. San Diego, CA: Academic Press, 1997: 125-44.
26. Jones NA, Turner J, McIlwrath AJ, Brown R, Dive C. Cisplatin-and Paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol 1998; 53:819-26.
27. Huang CC, Wu MC, Xu GW et al. Over-expression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J Natl Cancer Inst 1992; 84:262-4.
28. Mechetner E, Kyshtoobayeeva A, Zonis S et al. Levels of multidrug resistance (MDR-1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin Cancer Res 1998; 4:389-98.
29. Ferry DR. Testing the role of P-glycoprotein expression in clinical trials: applying pharmacological principles and best methods for detection together with good clinical trials methodology. Int J Clin Pharmacol Ther 1998; 36:29-40.
30. Shen DW, Lu YG, Chin KV, Pastan I, Gottesman MM. Human hepatocellular carcinoma cell lines exhibit multi-drug resistance unrelated to MDR1 gene expression. J Cell Sci 1991; 98(3):317-22.
31. Schiff PB, Fant T, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277:665-7.
32. Krajewski S, Chatten J, Hanada M, Reed JC. Immunohistochemical analysis of the bcl-2 oncoprotein in human neuroblastoma. Lab Invest 1995; 72:42-54.
33. L, by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 1995; 6:363-70.
34. Huang Y, Ibrado AM, Reed JC et al. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia 1997; 11:253-7.
35. Pepper C, Bentley P, Hoy T. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia. Br J Haematol 1996; 95:513-17.
36. S sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 1995; 55:2507-10.
37. 50, using the Probit technique: a basic computer program. Drug Chem Toxicol 1993; 6:111-16.